SUBSCRIBE
SUBSCRIBE
News   Drug Development

Pfizer Inc. Drug Tricks Immune System to Shrink Pancreatic Tumors in Research

March 25, 2011 | 
1 min read
Bloomberg -- An experimental drug made by Pfizer Inc. (PFE) slowed deadly pancreatic cancer in a study that revealed a new treatment approach that tricks the immune system to attack tissue protecting tumors, researchers said.
Clinical research Phase II
Pfizer
MORE ON THIS TOPIC
Pros and cons collage. Mixed media thumbs up and thumbs down hand gestures with speech bubbles. Review concept, positive and negative feedback vector illustration.
Immunology and inflammation
Sanofi Stumbles Again in Eczema—But Plans FDA Filing for OX40 Blocker Anyway
January 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Start early or business advantage. Businessman starts running ahead of competitors vector
Pain
Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase III for Non-Opioid Pill
January 22, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
From Sound Bites to Signals: Editors Parse Executive and Investor Chatter at JPM
January 22, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
MRI or magnetic resonance imaging of the head and brain. Close up
Insights
The New Gold Rush in Brain Science
January 22, 2026
 · 
5 min read
 · 
Jennifer Smith-Parker